Which has the lower trailing P/E, CHE or HQY?

CHE has the lower trailing P/E: CHE trades at 25.62 and HQY at 33.01. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, CHE or HQY?

Over the past five years, HQY grew revenue faster — CHE at a 4.12% CAGR versus HQY at 12.96%.

Does CHE or HQY pay a bigger dividend?

CHE pays a dividend (0.49% yield), while HQY has no payments in the available dividend history.

Is CHE or HQY more profitable?

HQY runs the higher net margin — CHE at 10.60% versus HQY at 17.36%.

How have CHE and HQY total returns compared?

Over the past 10 years, CHE delivered 14.19% and HQY delivered 9.16% annualized total return. Past performance doesn't predict future results.

Chemed Corporation (CHE) vs HealthEquity, Inc. (HQY)

A side-by-side comparison of Chemed Corporation and HealthEquity, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CHE

Chemed Corporation

$6.67B

$510.27HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT

HQY

HealthEquity, Inc.

$7.64B

$91.42HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT

Total return — CHE vs HQY

growth of $100 · dividends reinvested · last 10y

CHE +280.9% (+14.3%/yr)HQY +141.4% (+9.2%/yr)CHE compounded faster over this window

CHE HQY

CHE vs HQY: by the numbers

•HQY is the larger company ($7.64B vs $6.67B market cap).
•CHE trades at the lower trailing earnings multiple (25.62 vs 33.01 P/E), one valuation lens rather than an overall verdict.
•HQY converts more revenue to profit (17.36% vs 10.60% net margin).
•HQY grew revenue faster over the past five years (12.96% vs 4.12% CAGR).
•CHE pays a dividend (0.49% yield), while HQY has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	CHE	HQY
P/E ratio	25.62	33.01
Forward P/E	20.02	19.35
PEG ratio	N/A	0.40
P/S ratio	2.57	5.61
P/B ratio	8.03	3.84
EV / EBITDA	16.74	17.38
FCF yield	4.85%	6.17%

Profitability

Metric	CHE	HQY
Gross margin	30.44%	75.21%
Operating margin	13.46%	25.61%
Net margin	10.60%	17.36%
ROE	33.11%	11.88%
ROIC	19.48%	8.55%

Dividends

Metric	CHE	HQY
Dividend yield	0.49%	N/A
Payout ratio	12.55%	N/A

Growth (annualized)

Metric	CHE	HQY
Revenue CAGR (5Y)	4.12%	12.96%
EPS CAGR (5Y)	-1.65%	83.56%
FCF CAGR (5Y)	-5.44%	36.72%
Total return CAGR (5Y)	3.58%	7.00%

Frequently asked

Which has the lower trailing P/E, CHE or HQY?: CHE has the lower trailing P/E: CHE trades at 25.62 and HQY at 33.01. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, CHE or HQY?: Over the past five years, HQY grew revenue faster — CHE at a 4.12% CAGR versus HQY at 12.96%.
Does CHE or HQY pay a bigger dividend?: CHE pays a dividend (0.49% yield), while HQY has no payments in the available dividend history.
Is CHE or HQY more profitable?: HQY runs the higher net margin — CHE at 10.60% versus HQY at 17.36%.
How have CHE and HQY total returns compared?: Over the past 10 years, CHE delivered 14.19% and HQY delivered 9.16% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CHE analysis Full HQY analysis Interactive comparison tool

Dig into the metrics

Chemed P/E ratio HealthEquity P/E ratio Chemed dividend yield Chemed ROE HealthEquity ROE Chemed operating margin HealthEquity operating margin Chemed revenue growth HealthEquity revenue growth Chemed free cash flow HealthEquity free cash flow

Chemed & HealthEquity appear in these rankings

Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.